Virus News and Research

Latest Virus News and Research

Neutralizing antibody levels before symptomatic breakthrough infection in groups infected before and after Omicron emergence

Researchers assessed the levels of neutralizing antibodies in coronavirus disease patients.

9 Mar 2022

Rates of rapid antigen test positivity after day 5 from a positive COVID-19 test

A recent study evaluated the positivity rates of COVID-19 rapid antigen tests in infected individuals.

9 Mar 2022

Low SARS-CoV-2 diabetogenicity found in infected human pancreatic cells in vitro

Researchers assessed the diabetogenic potential of SARS-CoV-2 in a single cell in vitro analysis on the pancreatic islet cells.

9 Mar 2022

Mathematical model for evaluating factors driving SARS-CoV-2 transmission and pathogenesis

A new study provides an overview of the use of mathematical modeling to determine severe acute respiratory syndrome coronavirus 2 kinetics.

9 Mar 2022

Rabies transmission via vampire bats identified in Brazil

In a new study, researchers evaluated the concerns regarding the hematophagous bat-borne rabies in Brazil.

9 Mar 2022

One California university has unified town and gown to fight covid. Why haven’t others?

Once a week, Lori Janich drives down the street from her office and partakes in an ongoing success story. Phone in hand to confirm her appointment, she strolls into the massive Activities and Recreation Center on the University of California-Davis campus, reaches a covid-19 testing station, swirls water in her mouth, spits into a tube, and leaves. Within a day, she receives her test result.

9 Mar 2022

The CDC’s new guidelines on covid risk and masking elicit mixed feelings

When the Centers for Disease Control and Prevention last month unveiled updated covid-19 guidelines that relaxed masking recommendations, some people no doubt sighed in relief and thought it was about time.

9 Mar 2022

Intragenomic rearrangements help explain how SARS-CoV-2 variants arise

In a recent study posted to the bioRxiv* preprint server, researchers presented the intragenomic rearrangements of β-coronaviruses (CoVs), including severe acute respiratory syndrome CoV 2 (SARS-CoV-2).

9 Mar 2022

Lower exosome component 2 expression protects against clinical SARS-CoV-2 infection

In a recent study posted to the bioRxiv* preprint server, researchers demonstrated that the lower expression of EXOSC2 human protein safeguards from clinical coronavirus disease 2019 (COVID-19). This protective effect was via the reduced EXOSC2 expression-associated suppression of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication.

9 Mar 2022

Assessment of oligonucleotides as COVID-19 treatment

A recent study posted to the bioRxiv* pre-print server assessed the ability of oligonucleotides in preventing the development of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virions.

8 Mar 2022

Challenges and solutions for long-COVID

A recent study published in the Annals of Internal Medicine investigated the challenges and solutions associated with the unbiased estimation of post coronavirus disease 2019 (COVID-19) sequelae.

8 Mar 2022

Study suggests recent common cold may actually lead to worse COVID-19 disease

A new study published in the Journal of Infectious Diseases shines an unexpected light on the notion that pre-existing immunity to common cold coronaviruses can protect us from coronavirus disease 2019 (COVID-19) – and reveals that this may actually put certain individuals at risk of more severe clinical presentations.

8 Mar 2022

Researchers secure $12 million grant to develop improved therapies for hemophilia

An Indiana University School of Medicine researcher will lead a multi-institute effort toward improved therapies for hemophilia with help from a $12 million grant from the National Heart Lung and Blood Institute.

8 Mar 2022

Genetic sequencing may be a valuable tool to help identify geographic HIV transmission patterns

Sexual partnerships between individuals from different communities may help explain why some community-based HIV prevention efforts were moderately effective, shows a study published in eLife.

8 Mar 2022

Three new drug companies join the COVIDRIVE consortium to study vaccine effectiveness

Three new drug companies (Moderna, Novavax and Valneva) have joined the COVIDRIVE consortium, becoming partners of this project coordinated by the Vaccine Research Department of the Foundation for the Promotion of Health and Biomedical Research of Valencia Region (Fisabio), an affiliate of the Conselleria de Sanitat Universal i Salut Pública, along with the company specialized in pharmacovigilance and epidemiology, P95.

8 Mar 2022

Utilizing UV direct irradiation to combat airborne pathogens such as SARS-CoV-2

Researchers describe a method to safely sanitize an occupied room using ultraviolet (UV)-C radiation.

8 Mar 2022

A new view of SARS-CoV-2 genome structure

Researchers performed DMS mutational profiling with sequencing and DREEM clustering to determine the SARS-CoV-2 RNA secondary structure.

8 Mar 2022

Durable selenium nanoparticle fabrics with antiviral and antibacterial properties

Researchers graft SeNPs on polyester fabric through a flat screen-printing technique and observed their antimicrobial activity.

8 Mar 2022

Biotech spinout receives $42 million to develop 'future-proofed' coronavirus vaccines

Prime Minister Boris Johnson today announced that DIOSynVax, a biotech spinout of the University of Cambridge, will receive $42million to develop a vaccine candidate that could provide protection against both existing and future variants of SARS-CoV-2 - the virus that causes COVID-19 - as well as other major coronaviruses, including those that cause SARS and MERS.

8 Mar 2022

Third-party physicians prescribe more antibiotics through telehealth than hospital-affiliated doctors

During the COVID-19 pandemic, the demand for telemedicine boomed – increasing 63-fold among Medicare users alone from approximately 840,000 telehealth visits in 2019 to 52.7 million in 2020.

8 Mar 2022

Virus News and Research

Latest Virus News and Research

Neutralizing antibody levels before symptomatic breakthrough infection in groups infected before and after Omicron emergence

Rates of rapid antigen test positivity after day 5 from a positive COVID-19 test

Low SARS-CoV-2 diabetogenicity found in infected human pancreatic cells in vitro

Mathematical model for evaluating factors driving SARS-CoV-2 transmission and pathogenesis

Rabies transmission via vampire bats identified in Brazil

One California university has unified town and gown to fight covid. Why haven’t others?

The CDC’s new guidelines on covid risk and masking elicit mixed feelings

Intragenomic rearrangements help explain how SARS-CoV-2 variants arise

Lower exosome component 2 expression protects against clinical SARS-CoV-2 infection

Assessment of oligonucleotides as COVID-19 treatment

Challenges and solutions for long-COVID

Study suggests recent common cold may actually lead to worse COVID-19 disease

Researchers secure $12 million grant to develop improved therapies for hemophilia

Genetic sequencing may be a valuable tool to help identify geographic HIV transmission patterns

Three new drug companies join the COVIDRIVE consortium to study vaccine effectiveness

Utilizing UV direct irradiation to combat airborne pathogens such as SARS-CoV-2

A new view of SARS-CoV-2 genome structure

Durable selenium nanoparticle fabrics with antiviral and antibacterial properties

Biotech spinout receives $42 million to develop 'future-proofed' coronavirus vaccines

Third-party physicians prescribe more antibiotics through telehealth than hospital-affiliated doctors

A new way of characterising biomolecules eBook

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Newsletters you may be interested in